High-dose-rate interstitial brachytherapy for liver metastases: first study from India

PURPOSE: To study the safety and efficacy of high-dose-rate interstitial brachytherapy (HDRIBT) in patients with liver metastases (LM). MATERIAL AND METHODS: Between 2009 and 2011, 10 patients with 12 metastatic lesions in the liver were enrolled in this prospective trial. All patients had either re...

詳細記述

保存先:
書誌詳細
主要な著者: Sharma, Daya Nand, Thulkar, Sanjay, Sharma, Seema, Gandhi, Ajeet Kumar, Haresh, Kunhi Parambath, Gupta, Subhash, Rath, Goura Kisor, Julka, Pramod Kumar
フォーマット: Artigo
言語:Inglês
出版事項: Termedia Publishing House 2013
主題:
Original Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3708149/
https://ncbi.nlm.nih.gov/pubmed/23878550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2013.36175
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料